Emergent BioSolutions Inc. (EBS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 2.2900 |
| Open | 2.2700 |
| Bid | 0.0000 x 3200 |
| Ask | 0.0000 x 2200 |
| Day's Range | 2.1400 - 2.2985 |
| 52 Week Range | 1.4200 - 10.8800 |
| Volume | |
| Avg. Volume | 3,041,235 |
| Market Cap | 114.212M |
| Beta (5Y Monthly) | 1.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses
Key Insights Significantly high institutional ownership implies Emergent BioSolutions' stock price is sensitive to...
- GuruFocus.com
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
Net Loss Narrows in Q4; Full Year Revenues Hit Guidance Mid-Point
- Zacks
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales
Emergent (EBS) reports mixed earnings for fourth-quarter 2023. The company signs a forbearance agreement with its lenders, effective till April 2023-end.
© 2024 Yahoo. All rights reserved.